259 related articles for article (PubMed ID: 32452322)
1. Solid Lipid Nanoparticles for Topical Drug Delivery: Mechanisms, Dosage Form Perspectives, and Translational Status.
Liu M; Wen J; Sharma M
Curr Pharm Des; 2020; 26(27):3203-3217. PubMed ID: 32452322
[TBL] [Abstract][Full Text] [Related]
2. Solid lipid nanoparticles for transdermal delivery of avanafil: optimization, formulation, in-vitro and ex-vivo studies.
Kurakula M; Ahmed OA; Fahmy UA; Ahmed TA
J Liposome Res; 2016 Dec; 26(4):288-96. PubMed ID: 26784833
[TBL] [Abstract][Full Text] [Related]
3. Solid lipid nanoparticles for ocular drug delivery.
Seyfoddin A; Shaw J; Al-Kassas R
Drug Deliv; 2010; 17(7):467-89. PubMed ID: 20491540
[TBL] [Abstract][Full Text] [Related]
4. Histological assessment of follicular delivery of flutamide by solid lipid nanoparticles: potential tool for the treatment of androgenic alopecia.
Hamishehkar H; Ghanbarzadeh S; Sepehran S; Javadzadeh Y; Adib ZM; Kouhsoltani M
Drug Dev Ind Pharm; 2016; 42(6):846-53. PubMed ID: 26154267
[TBL] [Abstract][Full Text] [Related]
5. Applications and limitations of lipid nanoparticles in dermal and transdermal drug delivery via the follicular route.
Lauterbach A; Müller-Goymann CC
Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):152-63. PubMed ID: 26144664
[TBL] [Abstract][Full Text] [Related]
6. Design and evaluation of lidocaine- and prilocaine-coloaded nanoparticulate drug delivery systems for topical anesthetic analgesic therapy: a comparison between solid lipid nanoparticles and nanostructured lipid carriers.
You P; Yuan R; Chen C
Drug Des Devel Ther; 2017; 11():2743-2752. PubMed ID: 29075099
[TBL] [Abstract][Full Text] [Related]
7. Lipid Nanoparticles as a Skin Wound Healing Drug Delivery System: Discoveries and Advances.
de Souza ML; Dos Santos WM; de Sousa ALMD; de Albuquerque Wanderley Sales V; Nóbrega FP; de Oliveira MVG; Rolim-Neto PJ
Curr Pharm Des; 2020; 26(36):4536-4550. PubMed ID: 32303163
[TBL] [Abstract][Full Text] [Related]
8. Recent Advances in Lipid-Based Vesicles and Particulate Carriers for Topical and Transdermal Application.
Jain S; Patel N; Shah MK; Khatri P; Vora N
J Pharm Sci; 2017 Feb; 106(2):423-445. PubMed ID: 27865609
[TBL] [Abstract][Full Text] [Related]
9. Dermal Delivery of Lipid Nanoparticles: Effects on Skin and Assessment of Absorption and Safety.
Pinto F; Fonseca LP; de Barros DPC
Adv Exp Med Biol; 2022; 1357():83-114. PubMed ID: 35583641
[TBL] [Abstract][Full Text] [Related]
10. Sustained release of piroxicam from solid lipid nanoparticle as an effective anti-inflammatory therapeutics in vivo.
Peng LH; Wei W; Shan YH; Chong YS; Yu L; Gao JQ
Drug Dev Ind Pharm; 2017 Jan; 43(1):55-66. PubMed ID: 27498809
[TBL] [Abstract][Full Text] [Related]
11. Formulation optimization and in vitro skin penetration of spironolactone loaded solid lipid nanoparticles.
Kelidari HR; Saeedi M; Akbari J; Morteza-Semnani K; Gill P; Valizadeh H; Nokhodchi A
Colloids Surf B Biointerfaces; 2015 Apr; 128():473-479. PubMed ID: 25797482
[TBL] [Abstract][Full Text] [Related]
12. Lipid nanoparticles for dermal drug delivery.
Kakadia PG; Conway BR
Curr Pharm Des; 2015; 21(20):2823-9. PubMed ID: 25925115
[TBL] [Abstract][Full Text] [Related]
13. Full factorial design, physicochemical characterization, ex vivo investigation, and biological assessment of glutathione-loaded solid lipid nanoparticles for topical application.
Liu M; Sharma M; Lu GL; Zhang Z; Yin N; Wen J
Int J Pharm; 2023 Jan; 630():122381. PubMed ID: 36427694
[TBL] [Abstract][Full Text] [Related]
14. Development of SLNs from natural lipids: application to topical delivery of tretinoin.
Mandawgade SD; Patravale VB
Int J Pharm; 2008 Nov; 363(1-2):132-8. PubMed ID: 18657601
[TBL] [Abstract][Full Text] [Related]
15. Transport of stearic acid-based solid lipid nanoparticles (SLNs) into human epithelial cells.
Shah RM; Rajasekaran D; Ludford-Menting M; Eldridge DS; Palombo EA; Harding IH
Colloids Surf B Biointerfaces; 2016 Apr; 140():204-212. PubMed ID: 26764103
[TBL] [Abstract][Full Text] [Related]
16. Microwave-assisted formulation of solid lipid nanoparticles loaded with non-steroidal anti-inflammatory drugs.
Shah RM; Eldridge DS; Palombo EA; Harding IH
Int J Pharm; 2016 Dec; 515(1-2):543-554. PubMed ID: 27789371
[TBL] [Abstract][Full Text] [Related]
17. Solid lipid nanoparticle-based dissolving microneedles: A promising intradermal lymph targeting drug delivery system with potential for enhanced treatment of lymphatic filariasis.
Permana AD; Tekko IA; McCrudden MTC; Anjani QK; Ramadon D; McCarthy HO; Donnelly RF
J Control Release; 2019 Dec; 316():34-52. PubMed ID: 31655132
[TBL] [Abstract][Full Text] [Related]
18. Influence of various lipid core on characteristics of SLNs designed for topical delivery of fluconazole against cutaneous candidiasis.
Gupta M; Tiwari S; Vyas SP
Pharm Dev Technol; 2013; 18(3):550-9. PubMed ID: 21810069
[TBL] [Abstract][Full Text] [Related]
19. Astragaloside IV-loaded nanoparticle-enriched hydrogel induces wound healing and anti-scar activity through topical delivery.
Chen X; Peng LH; Shan YH; Li N; Wei W; Yu L; Li QM; Liang WQ; Gao JQ
Int J Pharm; 2013 Apr; 447(1-2):171-81. PubMed ID: 23500766
[TBL] [Abstract][Full Text] [Related]
20. Solid lipid nanoparticles: promising therapeutic nanocarriers for drug delivery.
Thukral DK; Dumoga S; Mishra AK
Curr Drug Deliv; 2014; 11(6):771-91. PubMed ID: 25469779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
